Article
Naringenin Restores Osteogenic Differentiation in TNF-α-Treated Bone Marrow Mesenchymal Stem Cells by Targeting AKR1B1
2025-03-20
Abstract excerpt
<title>Abstract</title> <p>Background Chronic inflammatory microenvironments, driven by cytokines like TNF-α, disrupt bone remodeling by suppressing osteogenic differentiation, contributing to inflammatory bone diseases. While TNF-α inhibitors mitigate inflammation, they lack osteoprotective effects. Naringenin, a citrus flavonoid with antioxidative and anti-inflammatory properties, shows potential but its mecha...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f5717896-e55a-54eb-b512-331107e94c55
- DOI
- 10.21203/rs.3.rs-6241423/v1
